Products aimed at sexual dysfunction and weight loss were the most common dietary supplements that contained hidden – and potentially harmful – ingredients.
Canadian doctors don’t have easy access to newer antibiotics, and must prescribe older, generic treatments that are increasingly ineffective due to resistance.
(Pexels/Shvets Production)
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Nearly 100 scholars and health care professionals are urging women to limit their use of acetaminophen during pregnancy.
Oscar Wong/Moment via Getty Images
Tylenol has long been considered a go-to medication for low to moderate pain and for fever reduction, even during pregnancy. But mounting evidence suggests that it is unsafe for fetal development.
The American Academy of Pediatrics says teens should never consume energy drinks.
monkeybusinessimages/istock via Getty Images
Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Antibiotics do not shorten or reduce the severity of colds or flu, but they could produce adverse effects that make you feel even worse.
(Pexels/Andrea Piacquadio)
Resistant bacteria aren’t the only risk posed by overprescribing antibiotics. A more immediate risk is side-effects and reactions, which a new review shows are surprisingly frequent and often severe.
The Biden administration can make significant changes in health care for Americans.
Joe Raedle via Getty Images
When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor’s office.
Prescription drugs in the U.S. are so costly, some people skip their medications.
Getty Images / Shana Novak
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
During the federal election campaign, Liberals promised to take critical steps to implement pharmacare. Will they deliver?
(Shutterstock)
To implement pharmacare, the Liberals will need to negotiate with the provinces, and the mostly Conservative premiers are unlikely to make this easy. The insurance industry also has much to lose.
When people went to their GP asking for painkillers, they weren’t prescribed higher doses of codeine or stronger opioids, as some feared.
from www.shutterstock.com
When codeine became a prescription only drug in 2018, the number of overdoses dropped, our new research shows. But restricting sales of codeine is only one way to reduce harm from opioids.
A letter to leaders of Canada’s political parties signed by 1200 academics with expertise in health care calls for parties to commit to a national pharmacare plan.
(Shutterstock)
The 1964 report that paved the way for Canada’s medicare envisaged that after universal coverage for doctors, the next step would be prescription drugs. But that next step hasn’t come.
When drug companies and drug regulators, such as Health Canada, sit down together at “pre-submission meetings” this may have a negative impact on public health.
(Shutterstock)
Three-quarters of people with an intellectual disability receive prescribed drugs.
U.S. President Donald Trump, Prime Minister Justin Trudeau and Mexico’s President Enrique Pena Nieto hold a news conference before signing the USMCA. The deal, if passed into law, poses dangers to public health.
(AP Photo/Pablo Martinez Monsivais)
The collective public health of Canada, the United States and Mexico will take a hit if the new NAFTA becomes law.
Research shows that six of 11 Health Canada scientific advisory committees had a majority of members with a direct or indirect financial interest.
(Shutterstock)
Alarming rise in deaths from two prescription drugs sees them reclassified as class C.
A new review of 372 patient group submissions to the Canadian Agency for Drugs or Technology in Health – about whether new medicines should be covered by public plans – reveals a total of 1896 conflicts of interest.
(Shutterstock)
A new study reveals how many patient groups lobby for new drugs to be funded by public plans in Canada – all while receiving funding from the companies manufacturing the drugs in question.